歡迎您來(lái)到深圳欣博盛生物科技有限公司網(wǎng)站!
Enzo Life Sciences的GFP-CERTIFIED® FLUOFORTE® Calcium assay kit提供了一種熒光分析方法,用于檢測(cè)廣泛生物靶標(biāo)的細(xì)胞內(nèi)鈣動(dòng)員情況。相對(duì)于其他商業(yè)化的染料,GFP-CERTIFIED® FLUOFORTE®染料是最亮和最-靈-敏的熒光鈣指示劑。該試劑盒為貼壁和非貼壁細(xì)胞系提供了更少步驟,更低變異性,更簡(jiǎn)易的鈣檢測(cè)。此外,它既不需要洗滌步驟,也不需要添加外源性淬滅染料,避免了對(duì)受體-配體相互作用動(dòng)力學(xué)的干擾。
Enzo Life Sciences的GFP-CERTIFIED® FLUOFORTE® Calcium assay kit可用于細(xì)胞內(nèi)鈣離子的高通量檢測(cè),鈣離子是重要的第二信使,常用于初步篩選中監(jiān)測(cè)G蛋白偶聯(lián)受體激活。
產(chǎn)品特色
● 可監(jiān)測(cè)表達(dá)GFP細(xì)胞中的鈣離子動(dòng)員情況
● 最明亮、最-靈-敏的熒光Ca2+指示劑
● 獲得的 EC50和IC50值與使用鈣離子熒光探針 Rhod-4 AM和Fluo-4 AM 相當(dāng)
● 更大范圍的檢測(cè)窗口
● 使用方便,無(wú)需洗滌,無(wú)需淬滅染料
實(shí)驗(yàn)示例
圖2. U-2 OS細(xì)胞分別與(A)GFP-CERTIFIED® FLUOFORTE®AM染料和(B)Rhod-2 AM染料孵育。洗滌細(xì)胞并用終濃度為100nM的ATP處理,并立即成像。GFP-CERTIFIED® FLUOFORTE® AM染料比Rhod-2 AM表現(xiàn)出更亮的熒光強(qiáng)度。
產(chǎn)品信息
產(chǎn)品貨號(hào) | ENZ-51020-KP010/ ENZ-51020-KP100 |
產(chǎn)品名稱 | GFP-CERTIFIED® FLUOFORTE® Calcium assay kit |
規(guī) 格 | 10*96wells/100*96wells |
短期保存 | -20°C |
長(zhǎng)期保存 | -80°C |
試劑盒組分 | Starter pack (Prod. No. ENZ-51020-KP010): Reagent A (lyophilized GFP-CERTIFIED® FLUOFORTE® dye), 1 vial Reagent B (dye efflux inhibitor), 10ml Reagent C (Hanks’ buffer with 20mM HEPES, 100ml) Sufficient for 10 x 96-well plates High-throughput (Prod. No. ENZ-51020-KP100): Reagent A (lyophilized GFP-CERTIFIED® FLUOFORTE® dye), 10 vials Reagent B (dye efflux inhibitor), 10 x 10ml Sufficient for 100 x 96-well plates |
部分產(chǎn)品引用文獻(xiàn)
1. Perfluorooctane sulfonate and bisphenol A induce a similar level of mast cell activation via a common signaling pathway, Fyn-Lyn-Syk activation: S.J. Park, et al.; Food Chem. Toxicol. 156, 112478 (2021)
2. horbol myristate acetate induces differentiation of THP-1 cells in a nitric oxide-dependent manner: Y.Y. Chang, et al.; Nitric Oxide 109, 33 (2021)
3. Absolute proteomic quantification reveals design principles of sperm flagellar chemosensation: C. Tr?tschel, et al.; EMBO J. 39, e102723 (2020)
4. Nanobody-directed targeting of optogenetic tools to study signaling in the primary cilium: J.N. Hansen, et al.; Elife 9, e57907 (2020)
5. Interplay between sub-cellular alterations of calcium release and T-tubular defects in cardiac diseases: M. Scardigli, et al.; Front. Physiol. 9, 1474 (2018)
6. Characterization of cholesterol homeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts reveals a Niemann-Pick disease type C-like phenotype: H. Vienken, et al.; Sci. Rep. 7, 43575 (2017)
7. Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy: C. Crocini, et al.; J. Mol. Cell. Cardiol. 91, 42 (2016)
8. Sulfur dioxide protects against collagen accumulation in pulmonary artery in association with downregulation of the transforming growth factor β1/smad pathway in pulmonary hypertensive rats: W. Yu, et al.; J. Am. Heart Assoc. 5, e003910 (2016)
9. T-tubular electrical defects contribute to blunted β-adrenergic response in heart failure: C. Crocini, et al.; Int. J. Mol. Sci. 17, 1471 (2016)
10. Defects in T-tubular electrical activity underlie local alterations of calcium release in heart failure: C. Crocini, et al.; PNAS 111, 15196 (2014)
詳情請(qǐng)聯(lián)系Enzo Life Sciences金牌代理——欣博盛生物